FDA Approved: TOLVAPTAN — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved Ascend Laboratories LLC's original ANDA for tolvaptan, a vasopressin V2 receptor antagonist, as a generic option for treating hyponatremia in adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hyponatremia
• Syndrome of Inappropriate Antidiuretic Hormone Secretion

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

ORIG AP for TOLVAPTAN (TOLVAPTAN)